Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction
Abstract Despite widespread preclinical success, mesenchymal stromal cell (MSC) therapy has not reached consistent pivotal clinical endpoints in primary indications of autoinflammatory diseases. Numerous studies aim to uncover specific mechanisms of action towards better control of therapy using in...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/782a48001def412f8bfcf8ee08491cdc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:782a48001def412f8bfcf8ee08491cdc |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:782a48001def412f8bfcf8ee08491cdc2021-12-02T12:32:35ZTherapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction10.1038/s41598-018-24971-22045-2322https://doaj.org/article/782a48001def412f8bfcf8ee08491cdc2018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-24971-2https://doaj.org/toc/2045-2322Abstract Despite widespread preclinical success, mesenchymal stromal cell (MSC) therapy has not reached consistent pivotal clinical endpoints in primary indications of autoinflammatory diseases. Numerous studies aim to uncover specific mechanisms of action towards better control of therapy using in vitro immunomodulation assays. However, many of these immunomodulation assays are imperfectly designed to accurately recapitulate microenvironment conditions where MSCs act. To increase our understanding of MSC efficacy, we herein conduct a systems level microenvironment approach to define compartmental features that can influence the delivery of MSCs’ immunomodulatory effect in vitro in a more quantitative manner than ever before. Using this approach, we notably uncover an improved MSC quantification method with predictive cross-study applicability and unveil the key importance of system volume, time exposure to MSCs, and cross-communication between MSC and T cell populations to realize full therapeutic effect. The application of these compartmental analysis can improve our understanding of MSC mechanism(s) of action and further lead to administration methods that deliver MSCs within a compartment for predictable potency.Matthew LiDanika KhongLing-Yee ChinAmy SingletonBiju ParekkadanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-12 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Matthew Li Danika Khong Ling-Yee Chin Amy Singleton Biju Parekkadan Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction |
description |
Abstract Despite widespread preclinical success, mesenchymal stromal cell (MSC) therapy has not reached consistent pivotal clinical endpoints in primary indications of autoinflammatory diseases. Numerous studies aim to uncover specific mechanisms of action towards better control of therapy using in vitro immunomodulation assays. However, many of these immunomodulation assays are imperfectly designed to accurately recapitulate microenvironment conditions where MSCs act. To increase our understanding of MSC efficacy, we herein conduct a systems level microenvironment approach to define compartmental features that can influence the delivery of MSCs’ immunomodulatory effect in vitro in a more quantitative manner than ever before. Using this approach, we notably uncover an improved MSC quantification method with predictive cross-study applicability and unveil the key importance of system volume, time exposure to MSCs, and cross-communication between MSC and T cell populations to realize full therapeutic effect. The application of these compartmental analysis can improve our understanding of MSC mechanism(s) of action and further lead to administration methods that deliver MSCs within a compartment for predictable potency. |
format |
article |
author |
Matthew Li Danika Khong Ling-Yee Chin Amy Singleton Biju Parekkadan |
author_facet |
Matthew Li Danika Khong Ling-Yee Chin Amy Singleton Biju Parekkadan |
author_sort |
Matthew Li |
title |
Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction |
title_short |
Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction |
title_full |
Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction |
title_fullStr |
Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction |
title_full_unstemmed |
Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction |
title_sort |
therapeutic delivery specifications identified through compartmental analysis of a mesenchymal stromal cell-immune reaction |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/782a48001def412f8bfcf8ee08491cdc |
work_keys_str_mv |
AT matthewli therapeuticdeliveryspecificationsidentifiedthroughcompartmentalanalysisofamesenchymalstromalcellimmunereaction AT danikakhong therapeuticdeliveryspecificationsidentifiedthroughcompartmentalanalysisofamesenchymalstromalcellimmunereaction AT lingyeechin therapeuticdeliveryspecificationsidentifiedthroughcompartmentalanalysisofamesenchymalstromalcellimmunereaction AT amysingleton therapeuticdeliveryspecificationsidentifiedthroughcompartmentalanalysisofamesenchymalstromalcellimmunereaction AT bijuparekkadan therapeuticdeliveryspecificationsidentifiedthroughcompartmentalanalysisofamesenchymalstromalcellimmunereaction |
_version_ |
1718394042158415872 |